Agenda
07:00 – 09:00 | Breakfast | ||
Session I | |||
09:00 – 09:10 | Welcoming remarks | ||
09:10 – 10:15 |
ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASESAt the end of this session, participants will be better able to:
|
||
10:15 – 10:45 | Break | ||
Session II | |||
10:45 – 12:00 |
“What have canadians learned about conquering
|
||
12:00 – 13:30 | Lunch | ||
Session III | |||
13:30 – 14:45 |
“B Cell Directed CAR T Cells: a Promising Tool for Systemic Autoimmune Diseases?”Michael Sebag, MD, PhD At the end of this session, participants will be better able to provide answers to the following questions:
|
||
15:00 – 15:30 | Break | ||
Session IV | |||
15:30 – 16:45 |
“The 2023 ACR/EULAR APS Classification Criteria from a Rheumatologist’s Perspective”Dr Antonio Cabral, MD At the end of this session, participants will be better able to:
|
||
18:00 | Poster Session | ||
19:00 |
Dinner & AwardsJeffrey-Shiroky Award: Dre Suzanne Morin Roger-Demers Award: Dr Vivian Bykerk Marie-Thérèse Fortin Award: Dre Nathalie Langlais |
07:00 – 09:00 | Breakfast | ||
Session V | |||
9:00 – 10:15 |
“State of the Art in Molecular Characterization of RA”
At the end of this session, participants will be better able to :
|
||
10:15 – 10:45 | Break | ||
Session VI | |||
10:45 – 12:00 |
“Pot-pourri en ostéoporose”
At the end of this session, participants will be better able to:
|
||
12:00 | Closing remarks |